HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.09
Day range
$1.07 - $1.13
Year range
$1.01 - $1.55
Market cap
29.59M USD
Avg Volume
52.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.04M | -14.71% |
Net income | -9.35M | 26.63% |
Net profit margin | — | — |
Earnings per share | -0.31 | 11.93% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.92M | -33.72% |
Total assets | 67.24M | -31.17% |
Total liabilities | 6.86M | -31.54% |
Total equity | 60.38M | — |
Shares outstanding | 27.40M | — |
Price to book | 0.49 | — |
Return on assets | -35.09% | — |
Return on capital | -38.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.35M | 26.63% |
Cash from operations | -6.38M | 46.91% |
Cash from investing | 6.11M | -67.36% |
Cash from financing | 48.00K | 108.70% |
Net change in cash | -217.00K | -103.22% |
Free cash flow | -3.09M | 55.47% |
About
Founded
2017
Headquarters
Website
Employees
22
